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Abstract Growth experiments of transplanted malignant
tumors in the presence of water-soluble C60 fullerenes were
performed on groups of mice. It was found that C60
fullerenes efficiently inhibit the growth of transplanted
malignant tumors. This behavior can be explained through
their high antioxidant activity and the blocking of the
specific cell receptors (for example, endothelial growth
factor). The findings demonstrate the possibility of using
C60 fullerenes in anticancer therapy.
Keywords C60 fullerenes .Mice line C57Bl/6J . Lewis lung
carcinoma . Tumor growth inhibition . Increasing of animal
life . Survival of animals . Metastasis inhibition index .
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1 Introduction
Malignant tumors are a major reason of the enhancement of
the disability and mortality rates. According to the World
Health Organization data, there were an estimated 12.4
million new cases of cancer worldwide in 2008 and 7.6
million deaths caused by the disease (Boyle and Levin
2008). The available methods at the present for the
treatment of tumors are not sufficiently effective. The
surgical removal of tumors is not always possible since
only a small percentage of onco-patients could be operated
and that the risk of postoperative complications is high.
Chemotherapy is a palliative method of treatment that
promotes short-term relief but does not lead to complete
recovery. In addition, it is toxic and causes serious
violations in the work of many organs, including liver and
heart. In this regard, there is a need to develop alternative
methods of tumor treatment and to find new substances,
which act locally in tumor, causing its destruction. One of
the mechanisms of such destruction is the simulation of
tumor cells death by necrosis or apoptosis with preserving
of normal cell viability. Biologically active non-toxic C60
fullerenes (Andrievsky et al. 2005; Prylutska et al. 2007;
Johnston et al. 2010), which are able to penetrate through the
membrane of cells (Foley et al. 2002) and have strong
antioxidant and antiviral properties (Prylutska et al. 2008;
Cataldo and Da Ros 2008), could be used for preventing the
growth of malignant neoplasms. In fact, some fullerene
derivatives have shown promising anticancer or antitumor
activity (Freitas 2003). Namely, Murugesan et al. (2007) have
demonstrated the substantial anti-angiogenic activity of
carbon materials such as graphite, multi-walled carbon nano-
tubes, and C60 fullerenes against either basic fibroblast growth
factor- or vascular endothelial growth factor-induced angio-
genesis in the chick chorioallantoic membrane model. It is
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known that an imbalance in the levels of these factors causes
many serious diseases including malignant cell growth
(Carmeliet 2005). Furthermore, Meng et al. (2010) have
reported that fullerene derivatives are capable to regulate in
low levels simultaneously more than ten angiogenic factors in
the mRNA level that is further confirmed at the protein level.
This result indicates that fullerene-containing materials serve
as a potent antiangiogenesis inhibitor that can simultaneously
target multiple angiogenic factors. In addition, Yin et al.
(2008, 2009) found that metallofullerene nanoparticles pene-
trate plasma membrane of tumor cells, effectively inhibit their
proliferation, and decrease the activities of those enzymes
which are responsible for catalyzing the production of reactive
oxygen species in vivo.
Considering the importance of using fullerenes for the
cancer treatment, the purpose of this work was mainly focused
on investigating the influence of pristine (unmodified) water-
soluble C60 fullerenes on the rate of growth of transplanted
malignant tumors.
2 Materials and methods
The C60 fullerene aqueous solutions (C60FAS) used for the
experiments were prepared as follows (Scharff et al. 2004):
a saturated solution of C60 fullerenes (purity 99.5%) in
toluene was mixed with the same amount of distilled water
and the resulted two-phase system was ultrasonicated until
the completion of the toluene evaporation. Afterwards, the
yellow-colored water phase was filtered for removing the
C60 fullerenes which were not dissolved. C60FAS samples
with concentrations of C60 fullerenes in water in the range
from 0.1 to 1.0 mg/ml were prepared. The C60FAS samples
were found to be stable for about 18 months at 4°C.
Theoretical calculations (Prilutsky et al. 1999; Bulavin et
al. 2000) showed that C60FAS contains both single C60
molecules and their clusters (with sizes of about 0.7–4 nm
depending of C60 fullerene concentration) in the hydrated
state. Moreover, C60 fullerenes structure the water, absorbed
by DNA molecules (Turov et al. 2010), and thus they can
affect the DNA functioning in the biosystem.
The state of C60 fullerenes in water was examined by
using STM technique (NT-MDT, Russia). The samples were
deposited on Au(111) surface by precipitation from aqueous
solution droplet.
It is important to note that used C60FAS does not
show a cytotoxic effect with respect to both normal and
transformed cells at concentrations below 1.0 mg/ml
(Prylutska et al. 2007).
The male mice of C57Bl/6J line (20–21 g weight) were
kept in a vivarium on a standard diet. The average
temperature in a vivarium was 20±1°C. We have to
mention that in all experiments performed in the present
work, we followed the international principles of European
Convention for protection of vertebrate animals.
Tumor transplantation (Lewis lung carcinoma) was
performed by intramuscular injection to the animal’s limb
(initial number of tumor cells was equal to ∼5×105;
antitumor effect) or to the pad of animal’s limb (initial
number of tumor cells was equal to ∼1×106; antimetastatic
effect). As is known, the strain of this tumor is characterized
by a high degree of lung metastases damage.
The C60FAS in the volume of 0.1 ml (the initial
concentration of C60 fullerenes in water was 1.0 mg/ml)
was injected intraperitoneal to the animals before the
transplantation of tumor (group 1; protective effect) one
time for 5 days with interval through a day. Injection of
C60FAS (0.1 ml) in group 2 (inhibitive effect) was started in
a day after the transplantation of tumor, which visually
appeared on the 10th day. The C60FAS was injected one
time for 5 days with interval through a day given the fact
that C60 fullerenes, introduced intraperitoneal to rats (dose
500 mg/kg), are excreted from the body within 2–4 days
(Gharbi et al. 2005). Finally, group 0 (mice with trans-
planted tumor without C60FAS injection) was used as
control. The initial number of animals in each group was
5 in experiment 1, 7 in experiment 2 (antitumor effect) and
also 7 in experiment 3 (antimetastatic effect). On the 20th
day of experiment 3, all animals were put to death for the
purpose of calculating the number of metastases in the lung of
each animal. It is also important to note that these experiments
were started in different time periods: experiment 1—middle
of autumn 2010; experiment 2—end of winter 2011; and
experiment 3—end of spring 2011.
The antitumor effectiveness of the applied technique was
estimated by following quantitative indicators:
– tumor growth inhibition (TGI, percent): kTGIi ¼
V0Vi
V0
 100%, where V0 and Vi are the average values
of tumor volume in animals of group 0 (control) and
experimental group i, respectively; V ¼ ðaþbÞ316 , where a
and b are the length and width (in millimeters) of the
tumor site;
– increasing of animal life (IAL, percent): kIALi ¼
tit0
t0
 100%, where t0 and ti are the average life span
of animals (in days) in group 0 (control) and
experimental group i, respectively;
– survival of animals of experimental group i compared
with control (kSAi , percent);
– metastasis inhibition index (MII, percent): kMII1 ¼
A0B0A1B1
A0B0  100%, where A0 and A1 are frequency of
metastasis in the group 0 (control) and experimental
group 1, respectively; B0 and B1 are the average number
of metastases in certain organ of animals in group 0
(control) and experimental group 1, respectively.
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Within the histological studies, the tumor was fixed in
4% paraformaldehyde solution in phosphate buffer pH 7.4,
dehydrated in alcohols of increasing concentration and
poured in paraplast of U.S. production (Richard-Allan
Scientific). The microscopic sections (thickness of 5 μm)
were obtained using the rotary microtome (Leaica RM
21225 RT, Germany) and colored by Erlich hematoxylin
and eosin. These sections were studied using the light
optical microscope (Olympus BX51, Japan). The average
number of mitotic and apoptotic cells, and the mitotic and
apoptotic indices were determined by counting ten regions
of view (each of them contained ∼500 cells) with
magnification 400×. The percentage of area occupied by
necrosis was estimated using the “Olympus DP-Soft”
morphometric software.
The statistical analysis of obtained results was performed
using STATISTICA software package including numerical
methods (Gubler 1978).
3 Results and discussion
The STM images of submonolayer C60 fullerene film
deposited from aqueous solution (C60 fullerene concentra-
tion in water was 1.0 mg/ml) on Au(111) surface are shown
in Fig. 1. The images reveal almost random arrangement of
C60 fullerene clusters with sizes up to ∼2.8 nm (the first
stable sphere-like cluster consisting of 13 hydrated C60
fullerenes (Prilutsky et al. 1999; Bulavin et al. 2000)
(Fig. 1a). Despite the high mobility of C60 molecules on Au
(111) at the room temperature, images of single C60
molecules were also made (Fig. 1b).
The results extracted from experiment 1 (antitumor
effect) are presented in Table 1. Antitumor effect of C60
fullerenes was recorded on the 15th day after transplantation
of tumor in group 1 (protective effect; 25th day after the
introduction of C60 fullerenes) and in group 2 (inhibitive
effect). Inhibition of tumor growth in group 1 shows a
tendency to decrease from 17.0% (15th day) to 3.1% (25th
day after tumor transplantation). Inhibition of tumor growth
in group 2 increased from 30.0% (15th day), reached a
maximum of 37.2% (18th day) and then decreased to 16.0%
(25th day after tumor transplantation). The last animal in the
control group 0 died on the 32th day of the experiment. The
survival of animals in groups 1 and 2 was 20.0% and 40.0%,
respectively, compared to the control. Finally, the life
duration for last animal in group 1 (protective effect) and
group 2 (inhibitive effect) (38 days) was about 1.2 times
higher compared to the control (31 days).
The results obtained from experiment 2 (antitumor
effect) are presented in Table 2. Antitumor effect of C60
fullerenes was recorded on the 13th day after transplanta-
tion of tumor in group 1 (protective effect; 23th day after
the introduction of C60 fullerenes) and in group 2
(inhibitive effect). Inhibition of tumor growth in group 1
shows a tendency to increase (in contrast to the results of
experiment 1) from 15.0% (13th day) to the maximum
value of 35.0% (27th day after tumor transplantation).
Inhibition of tumor growth in group 2 reached a maximum
of 25.1% (16th day) and then decreased to 5.0% (27th day
after tumor transplantation). The last animal in the control
group 0 died on the 30th day of the experiment. The
survival of animals in groups 1 and 2 was 28.6% and
85.7%, respectively, compared to the control. These values
were higher compared with those obtained in experiment 1.
The extension of animal life in group 1 was found to be
30.3% while in group 2 was estimated to be 21.8%
compared to the control. Finally, the life duration for last
animal in group 1 (53 days) (protective effect) and group 2
(36 days) (inhibitive effect) was accordingly ∼1.8 and ∼1.2
Fig. 1 a Large-scale STM
image of submonolayer C60
fullerene film deposited from
aqueous solution (C60 fullerene
concentration in water was
1 mg/ml) on Au(111) surface.
Some C60 fullerene clusters are
aligned along preferential
direction <112>. b Single C60
fullerenes. Lateral size is in-
creased because of shape of
the tip. Inset: cross-section along
line AB. Scanning parameters:
It=40 pA, Ut=0.7 V
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times greater compared to the control (29 days) (this value
agrees well with a same for group 2 in experiment 1).
For visual comparison of tumor growth, Fig. 2 presents
the animals in group 2 (inhibitive effect; Fig. 2a) and group
1 (protective effect; Fig. 2b) on 34th day after tumor
transplantation. Estimations demonstrate that the average
tumor volume in experimental group 2 (inhibitive effect) is
about ∼1.7 times greater compared to that in group 1
(protective effect).
It is also important to note that the visual observation of
experimental animals revealed that animals in group 1
(protective effect) compared to the animals in group 2
(inhibitive effect) have greater mobility and that the color of
their hair was more explicit shade. Finally, the life duration
for last animal in group 1 (protective effect) seems to be
about ∼1.5 times greater compared to that of last animals in
group 2 (inhibitive effect).
The results obtained from experiment 3 (antimetastatic
effect) clearly demonstrate that the metastasis inhibition
index for group 1 (protective effect) ðkIIM1 ¼ 96%Þ is twice
the value of this index for group 2 (inhibitive effect)
ðkIIM2 ¼ 48%Þ on the 20th day after tumor transplantation.
Figure 3 presents the histological data for the animal
tumors of group 0 (control; Fig. 3a), group 1 (protective
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inhibition*, kTGI2 , %
15 n=5 n=5 17.0 n=5 30.0
18 n=5 n=5 4.0 n=5 37.2
20 n=5 n=4 13.0 n=5 19.4
22 n=4 n=4 11.3 n=5 13.6
25 n=3 n=3 3.1 n=4 16.0
27 n=2 n=2 n=2
32 n=0 n=1 ðkSA1 ¼ 20:0%Þ n=2 ðkSA2 ¼ 40:0%Þ
35 n=1 n=1
39 n=0 n=0
Start of C60FAS injection before the tumor transplantation—12 October 2010 (group 1; protective effect). Start of tumor transplantation—22
October 2010. Start of C60FAS injection after the tumor transplantation—24 October 2010 (group 2; inhibitive effect). Initial number of animals in
experimental groups was n=5. Survival of animals (kSAi , percent) is given in parentheses
*p<0.05, the differences are statistically valid compared with the control








inhibition*, kTGI1 , %




inhibition*, kTGI2 , %
13 n=7 n=7 15.0 n=7 4.0
16 n=7 n=7 27.2 n=7 25.1
21 n=7 n=7 25.0 n=7 5.4
23 n=4 n=7 23.3 n=7 17.0
27 n=2 n=6 35.0 n=6 5.0
29 n=2 n=3 n=6
30 n=0 n=2 ðkSA1 ¼ 28:6%Þ n=6 ðkSA2 ¼ 85:7%Þ
33 n=2 n=4
34 n=2 n=2
37 n=2 n=0 ðkIAL2 ¼ 21:8%Þ*
54 n=0 ðkIAL1 ¼ 30:3%Þ*
Start of C60FAS injection before the tumor transplantation—07 February 2011 (group 1; protective effect). Start of tumor transplantation—17
February 2011. Start of C60FAS injection after the tumor transplantation—19 February 2011 (group 2; inhibitive effect). Initial number of animals
in experimental groups was n=7. Survival of animals (kSA1 , %) and increasing of animal life (k
IAL
i , %) are given in parentheses
*p<0.05, the differences are statistically valid compared with the control
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effect; Fig. 3b) and group 2 (inhibitive effect; Fig. 3c) on
the 20th day after tumor transplantation in experiment 3
(antimetastatic effect).
Lewis lung carcinoma consists of polymorphic cells,
most of which are occupied by the nucleus with large
nucleolus, condensed chromatin and light areas of karyo-
plasm. Mitosis, apoptosis and necrosis of tumor cells are
observed in all groups (Fig. 3). The isolated lymphocytes
are presented in the tumor stroma, and infiltration of
polymorphonuclear leukocytes is observed. Morphometric
studies show the differences in the area of necrosis, mitotic
and apoptotic indices between the study group and control,
namely: area of necrosis in tumors was 17.7% (control),
12.7% (group 1; protective effect) and 8.3% (group 2;
inhibitive effect); the mitotic index was 1.57 (control), 1.20
(group 1; protective effect) and 1.82 (group 2; inhibitive
effect); the apoptotic index was 2.0 (control), 4.7 (group 1;
protective effect) and 2.9 (group 2; inhibitive effect). As
can be seen, the area in the tumor necrosis and apoptotic
index value for group 1 (protective effect) exceed these
parameters for group 2 (inhibitive effect). Conversely, the
value of mitotic index for group 1 (protective effect) is less
Fig. 2 Visual comparison of tumor size for animals of group 2
(inhibitive effect; a) and group 1 (protective effect; b): 34th day after
tumor transplantation (experiment 2 (antitumor effect))
Fig. 3 Histological sections of Lewis lung carcinoma in male mice of
C57Bl/6J line on the 20th day after tumor transplantation (Experiment
3 (antimetastatic effect): start of tumor transplantation—20 May
2011. Start of C60FAS injection after tumor transplantation—22
May 2011): a (control)—small areas of necrosis of tumor cells,
apoptosis (200×); b (group 1; protective effect)—mitosis and
apoptosis of tumor cells (400×); c (group 2; inhibitive effect)—
areas of necrosis of tumor cells (200×)
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than this parameter for group 2 (inhibitive effect). Thus, C60
fullerenes, which were injected to animals before the tumor
transplantation (protective effect), activate processes of
necrosis and apoptosis of tumor cells, and C60 fullerenes,
which are injected to animals after the tumor transplantation
(inhibitive effect), activate the process of mitosis of tumor
cells.
4 Conclusion
C60FAS, without showing direct cytotoxicity, cause at low
single therapeutic dose (5 mg/kg) antitumor immune
response. Specifically, it was observed that a treatment
with C60FAS inhibits tumor volume of Lewis lung
carcinoma in male mice of C57Bl/6J line. Namely, within
the study of protective effect of C60FAS, it was found that
the maximum therapeutic effect was reached 35.0% for the
index of tumor growth inhibition. The survival of animals
was 28.6% compared to the control. An extension of animal
life of about 30.3% was found. Within the study of
inhibitive effect of C60FAS, the treatment purposefully
suppresses the growth of this tumor: the maximum
therapeutic effect reached 25.1% for the index of tumor
growth inhibition; the survival of animals was 85.7%
compared to the control; and an extension of animal life
of about 21.8% was found. The metastasis inhibition index
was 96% for protective effect and 48% for inhibitive effect
of C60FAS. Finally, the anticancer effect of C60FAS was
confirmed by histological data. The obtained results can be
explained as a result of the high antioxidant activity of C60
fullerenes, neutralizing excess reactive oxygen species in
the cell and possibly blocking the specific cell receptors, for
example, endothelial growth factor. The proposed treatment
with C60FAS can be very promising in clinical oncology for
the inhibition of tumor growth (Prylutska et al. 2011).
Acknowledgments This work was partly supported by BMBF
grant.
References
Andrievsky G, Klochkov V, Derevyanchenko L (2005) Is the C60
fullerene molecule toxic?! Fullerenes, Nanotubes, and Carbon
Nanostruct 13:363–376
Boyle P, Levin B (2008) World cancer report. WHO, Lyon
Bulavin L, Adamenko I, Prylutskyy Yu, Durov S, Graja A, Bogucki A,
Scharff P (2000) Structure of fullerene C60 in aqueous solution.
Phys Chem Chem Phys 2:1627–1629
Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature
438:932–936
Cataldo F, Da Ros T (eds) (2008) Medicinal chemistry and
pharmacological potential of fullerenes and carbon nanotubes.
Series: Carbon materials: chemistry and physics. Springer,
Netherlands
Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P,
Larroque Ch (2002) Cellular localisation of a water-soluble
fullerene derivative. Biochem Biophys Res Commun
294:116–119
Freitas RA Jr (2003) Nanomedicine, volume IIA: biocompatibility.
Landes Bioscience, Georgetown
Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F
(2005) C60 fullerene is a powerful antioxidant in vivo with no
acute or subacute toxicity. Nano Lett 5:2578–2585
Gubler EV (1978) Computational methods of analysis and recognition
of pathological processes. Medicine, Moscow
Johnston HJ, Hutchison GR, Christensen FM, Aschberger K, Stone V
(2010) The biological mechanisms and physicochemical charac-
teristics responsible for driving fullerene toxicity. Toxicol Sci
114:162–182
Meng H, Xing G, Sun B, Zhao F, Lei H, Li W et al (2010) Potent
angiogenesis inhibition by the particulate form of fullerene
derivatives. ASC Nano 4:2773–2783
Murugesan S, Mousa SA, O’Connor LJ, Lincoln DW, Linhardt RJ
(2007) Carbon inhibits vascular endothelial growth factor- and
fibroblast growth factor-promoted angiogenesis. FEBS Lett
581:1157–1160
Prylutska SV, Matyshevska OP, Golub AA, Prylutskyy YuI, Potebnya
GP, Ritter U, Scharff P (2007) Study of C60 fullerenes and C60-
containing composites cytotoxicity in vitro. Mater Sci Engineer
C 27:1121–1124
Prylutska SV, Grynyuk II, Matyshevska OP, Prylutskyy YuI, Ritter U,
Scharff P (2008) Anti-oxidant properties of C60 fullerenes in
vitro. Fullerenes, Nanotubes, and Carbon Nanostruct 16:698–705
Prylutska SV, Burlaka AP, Prylutskyy YuI (2011) Application of
unmodified C60 fullerenes as anticancer agents in the therapy of
malignant tumors. Patent of Ukraine for an invention N
a201104882, 14 April 2011
Prilutsky YuI, Durov SS, Yashchuk VN, Ogul’chansky TYu, Pogorelov
VE, Astashkin YuA, Buzaneva EV, Kirghizov YuD, Andrievsky
GV, Scharff P (1999) Theoretical predictions and experimental
studies of self-organization C60 nanoparticles in water solution
and on the support. Eur Phys J D 9:341–343
Scharff P, Risch K, Carta-Abelmann L, Dmytruk IM, Bilyi MM,
Golub OA, Khavryuchenko AV, Buzaneva EV, Aksenov VL,
Avdeev MV, Prylutskyy YuI, Durov SS (2004) Structure of C60
fullerene in water: spectroscopic data. Carbon 42:1203–1206
Turov VV, Chehun VF, Krupskaya TV, Barvinchenko VN, Chehun SV,
Ugnichenko AP, Prylutskyy YuI, Scharff P, Ritter U (2010) Effect
of small addition of C60 fullerenes on the hydrated properties of
nanocomposites based on highly dispersed silica and DNA.
Chem Phys Lett 496:152–156
Yin JJ, Lao F, Fu PP, Zhao Y, Xing G, Gao X et al (2008) Inhibition of
tumor growth by endohedral metallofullerenol nanoparticles
optimized as reactive oxygen species scavenger. Mol Pharmacol
74:1132–1140
Yin JJ, Lao F, Fu PP, Wamer WG, Zhao Y, Wang PC et al (2009) The
scavenging of reactive oxygen species and the potential for cell
protection by functionalized fullerene materials. Biomaterials
30:611–621
110 S.V. Prylutska et al.
